Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04396678 · ClinicalTrials.gov registry record · NA
Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women
A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT04396678 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 39 participants.
The verdict
NCT04396678, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy on adherence of a community-informed intervention for tenofovir/emtricitabine (TDF/FTC) pre-exposure prophylaxis (PrEP) engagement among street-based female sex workers (FSW) in Baltimore, Maryland.
Interventions
- BEHAVIORAL PrEP standard of care+behavioral intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-06-12 |
| Est. Completion | 2020-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04396678
The ClinicalTrials.gov registry entry for NCT04396678 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which PrEP standard of care+behavioral intervention is the first listed.
NCT04396678 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04396678 about?
NCT04396678 is a clinical study titled "Developing a PrEP Adherence Intervention Targeting At-Risk and Substance Using Women". The purpose of this study is to develop and assess the feasibility, acceptability, and preliminary efficacy on adherence of a community-informed intervention for tenofovir/emtricitabine (TDF/FTC) pre-exposure prophylaxis (PrEP) engagement among street-based female sex workers (FSW) in Baltimore, Mar...
What is the current status of trial NCT04396678?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2019-06-12. Estimated completion is 2020-12-01.
What interventions are being tested in trial NCT04396678?
The interventions under investigation include: PrEP standard of care+behavioral intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT04396678?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.